Healthcare News – Read More Federal regulators approved a first-of-its-kind cholesterol medication from Merck that rivals the effectiveness of powerful drugs already on the market. The Food and Drug Administration (FDA) greenlighted the once-daily pill called Lipfendra, which reduces “bad” or low-density lipoprotein cholesterol (LDL-C) in adults by inhibiting the production of PCSK9 proteins. Lipfendra is the first drug that…
FDA approves first daily pill to drastically lower cholesterol levels
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
